Old Web
English
Sign In
Acemap
>
authorDetail
>
Jee Sun Yoon
Jee Sun Yoon
Seoul National University Hospital
Medicine
DNA damage
Olaparib
Durvalumab
Internal medicine
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DNA-damage response-umbrella study of the combination of ceralasertib and olaparib, or ceralasertib and durvalumab in advanced biliary tract cancer: A phase 2 trial-in-progress.
2021
Journal of Clinical Oncology
Jee Sun Yoon
Jin Won Kim
Ji-Won Kim
Tae Yong Kim
Ah-Rong Nam
Ju-Hee Bang
Hye-Rim Seo
Jae-Min Kim
Kyoung-Seok Oh
P. Mortimer
Simon Smith
Do-Youn Oh
Show All
Source
Cite
Save
Citations (0)
Biomarker-oriented study of durvalumab in combination with olaparib and paclitaxel in gastric cancer: A phase 2 trial-in-progress.
2021
Journal of Clinical Oncology
Tae Yong Kim
Jee Sun Yoon
Ah-Rong Nam
Ju-Hee Bang
Kyoung-Seok Oh
Hye-Rim Seo
Jae-Min Kim
Do-Youn Oh
Show All
Source
Cite
Save
Citations (0)
1